June 19 (Reuters) - Vanda Pharmaceuticals said on Wednesday that it has rejected takeover offers UK-based Cycle Pharmaceutical and a revised bid from contract manufacturer Future Pak, adding that both offers undervalue the U.S. drugmaker.

(Reporting by Gursimran Kaur in Bengaluru; Editing by Rashmi Aich)